Endpoints News 生物医药· Nicole DeFeudis·· 26 天前AI 评分23
ESMO26:默克与Moderna的个性化癌症疫苗数据为“科学的胜利”,工作正式开始
#ESMO26: Merck and Moderna's cancer vaccine data were 'a triumph of science.' And now, the work begins
AI 导读
在ESMO26会议上,默克与Moderna发布的个性化癌症疫苗数据被评价为“科学的胜利”,相关工作正式开启。临床医生对该数据表现出浓厚兴趣,但具体研究结果和后续进展因原文订阅限制未完全披露。
正文
MADRID — In a testament to clinicians’ interest in Merck and Moderna’s personalized cancer vaccine data at this year’s European Society for Medical Oncology conference, the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news